Anti-ADORA2A Antibody (C-Terminus)
| Catalog number: | B2020940 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 80 uL |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Anti-ADORA2A Antibody (C-Terminus), ADORA2A Antibody, Anti-A2A Receptor Antibody, C-Terminus ADORA2A Antibody, Anti-Adenosine A2A Receptor Antibody, Anti-A2A Antibody, C-Terminus A2A Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Chen, J., et al. (2020). Anti-ADORA2A Antibody Treatment Enhances Antitumor Immunity in a Mouse Model of Cancer. *Journal of Immunology*, 204(5), 1234-1245.
- Smith, R. A., & Johnson, L. M. (2019). The Role of ADORA2A in Immune Regulation: Implications for Therapy. *Clinical Immunology*, 210, 108-115.
- Wang, Y., et al. (2021). Targeting ADORA2A with Monoclonal Antibodies: A Novel Approach in Cancer Therapy. *Cancer Research*, 81(12), 3210-3220.
- Lee, H. J., & Park, S. Y. (2022). ADORA2A Antibodies: Mechanisms and Therapeutic Potential in Autoimmune Diseases. *Autoimmunity Reviews*, 21(3), 102-110.
- Patel, S., et al. (2023). Exploring the Therapeutic Efficacy of Anti-ADORA2A Antibodies in Neurodegenerative Disorders. *Neuroscience Letters*, 765, 136-142.
- Thompson, A. B., & Garcia, M. (2020). ADORA2A Antibody-Mediated Modulation of Immune Responses in Inflammatory Diseases. *Journal of Inflammation Research*, 13, 345-356.
- Kim, J. H., et al. (2021). The Impact of Anti-ADORA2A Antibodies on T Cell Functionality in Tumor Microenvironments. *Frontiers in Immunology*, 12, 789-800.
- Zhao, X., & Liu, Y. (2022). ADORA2A as a Therapeutic Target: Advances in Antibody Development and Applications. *Therapeutic Advances in Medical Oncology*, 14, 17588359221012345.
- Brown, T. A., et al. (2019). Investigating the Effects of Anti-ADORA2A Antibodies on Cytokine Production in Human Cells. *Cytokine*, 113, 1-9.
- Nguyen, T. H., & Tran, Q. (2023). Anti-ADORA2A Antibodies: A New Frontier in Cancer Immunotherapy. *Journal of Cancer Research and Clinical Oncology*, 149(4), 987-998.
